Acadia Healthcare Company (ACHC) Rebounds Sharply, Is The Stock Still A Bargain?

Acadia Healthcare Company (ACHC) is back in focus after a recent share price move, with the stock closing at US$28.06. That shift gives investors fresh context for its behavioral health footprint.

The latest move comes after a sharp year-to-date share price return of 96.36%, even as the 1-year total shareholder return is a more modest 3.39% and the 3-year total shareholder return has declined 59.50%. This points to momentum rebuilding after a tough multi-year stretch for Acadia Healthcare Company.

Scan beyond Acadia Healthcare Company and compare its rebound with 19 high quality undiscovered gems that analysts might be overlooking.

After a near doubling in the year to date, followed by a softer 3-year record and a recent pullback, does stepping into Acadia Healthcare Company now offer a better approach than waiting for a cleaner entry on the chart and additional valuation work?

Most Popular Narrative: 17% Undervalued

Against Acadia Healthcare Company's last close at $28.06, the most followed narrative pegs fair value nearer $33.79, so the market view in that framework implies meaningful upside that rests heavily on execution and legal overhangs easing over time.

Significant start-up losses tied to rapid facility expansion (projected at $60 to $65 million for 2025), coupled with recent pauses on expansion to preserve free cash flow, signal potential execution risk in managing capital allocation, which could suppress near-term net earnings and constrain future revenue growth if new facility ramps continue to lag expectations.

See why 2 investors see Acadia Healthcare Company as 17% undervalued.

Result: Fair Value of $33.79 (UNDERVALUED)

Still, pressure from higher malpractice related expenses and underperforming facilities that are dragging on EBITDA could quickly challenge the case that Acadia Healthcare Company is undervalued.

Find out about the key risks to this Acadia Healthcare Company narrative.

Next Steps

Sentiment on Acadia Healthcare Company is clearly mixed, with real concerns and genuine optimism sitting side by side. Review the data yourself and move quickly to form your own take by weighing the 3 key rewards and 1 important warning sign

Looking for more investment ideas beyond Acadia Healthcare Company?

Before you move on from Acadia Healthcare Company, take a moment to line up your next ideas using focused stock lists built from the Simply Wall Street Screener.

• Target resilience by scanning 31 resilient stocks with low risk scores to help keep portfolio volatility in check when individual positions move around.
• Spot potential value setups through 31 high quality undervalued stocks which combine quality fundamentals with pricing that may not fully reflect their financial profile.
• Broaden your watchlist with 8 elite penny stocks with strong financials that pair smaller market caps with stronger balance sheets and fundamentals than many peers in the same price bracket.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com